These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8334836)

  • 1. Limitations of the polyol hypothesis in the pathobiology of experimental diabetic neuropathy.
    Tomlinson DR; Carrington AL; Diemel LT; Ettlinger CB; Smith WJ; Fernyhough P
    Diabet Med; 1993; 10 Suppl 2():27S-30S. PubMed ID: 8334836
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy.
    Shindo H; Tawata M; Aida K; Onaya T
    J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.
    Tomlinson DR; Robinson JP; Compton AM; Keen P
    Diabetologia; 1989 Sep; 32(9):655-9. PubMed ID: 2477293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal transport and nerve conduction velocity in animal models of diabetic neuropathy.
    Tomlinson DR; Mayer JH
    Diabet Med; 1985 May; 2(3):210-2. PubMed ID: 2952422
    [No Abstract]   [Full Text] [Related]  

  • 5. A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats.
    Yasuda H; Sonobe M; Hatanaka I; Yamashita M; Miyamoto Y; Terada M; Amenomori M; Kikkawa R; Shigeta Y; Motoyama Y
    Biochem Biophys Res Commun; 1988 Jan; 150(1):225-30. PubMed ID: 3276309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats.
    Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M
    Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat.
    Stevens MJ; Lattimer SA; Kamijo M; Van Huysen C; Sima AA; Greene DA
    Diabetologia; 1993 Jul; 36(7):608-14. PubMed ID: 8359577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima W
    Prostaglandins; 1995 Jun; 49(6):339-49. PubMed ID: 7480803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
    Mayer JH; Tomlinson DR
    Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxic neuropathy versus diabetic neuropathy. An electrophysiological study in rats.
    Hendriksen PH; Oey PL; Wieneke GH; van Huffelen AC; Gispen WH
    J Neurol Sci; 1992 Jul; 110(1-2):99-106. PubMed ID: 1506876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 4-methylcatechol on sciatic nerve growth factor level and motor nerve conduction velocity in experimental diabetic neuropathic process in rats.
    Hanaoka Y; Ohi T; Furukawa S; Furukawa Y; Hayashi K; Matsukura S
    Exp Neurol; 1992 Feb; 115(2):292-6. PubMed ID: 1735473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on WF-3681, a novel aldose reductase inhibitor. IV. Effect of FR-62765, a derivative of WF-3681, on the diabetic neuropathy in rats.
    Nishikawa M; Yoshida K; Okamoto M; Itoh Y; Kohsaka M
    J Antibiot (Tokyo); 1991 Apr; 44(4):441-4. PubMed ID: 1903376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of sorbitol in the sciatic nerve modulates circadian properties of diabetes-induced neuropathic pain hypersensitivity in a diabetic mouse model.
    Akamine T; Kusunose N; Matsunaga N; Koyanagi S; Ohdo S
    Biochem Biophys Res Commun; 2018 Sep; 503(1):181-187. PubMed ID: 29864425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
    Kishi Y; Schmelzer JD; Yao JK; Zollman PJ; Nickander KK; Tritschler HJ; Low PA
    Diabetes; 1999 Oct; 48(10):2045-51. PubMed ID: 10512372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Lund DD; Yorek MA
    Diabetes; 2001 Aug; 50(8):1927-37. PubMed ID: 11473057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental Diabetic Neuropathy.
    Freeman OJ; Unwin RD; Dowsey AW; Begley P; Ali S; Hollywood KA; Rustogi N; Petersen RS; Dunn WB; Cooper GJ; Gardiner NJ
    Diabetes; 2016 Jan; 65(1):228-38. PubMed ID: 26470786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Maxfield EK
    Diabetologia; 1993 Apr; 36(4):299-304. PubMed ID: 8477873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new prostaglandin E1 analogue (TFC-612) improves the reduction in motor nerve conduction velocity in spontaneously diabetic GK (Goto-Kakizaki) rats.
    Suzuki K; Saito N; Sakata Y; Toyota T; Goto Y
    Prostaglandins; 1990 Nov; 40(5):463-71. PubMed ID: 2255766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
    Maxfield EK; Cameron NE; Cotter MA; Dines KC
    Diabetologia; 1993 Dec; 36(12):1230-7. PubMed ID: 8307249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sorbitol pathway in neuropathy.
    Gabbay KH
    Adv Metab Disord; 1973; 2():Suppl 2:417-32. PubMed ID: 4269012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.